Activated Blood Coagulation Factor X (Fxa) Inhibitor

Patent No. EP2374456 (titled "Activated Blood Coagulation Factor X (Fxa) Inhibitor") was filed by Daiichi Sankyo on Dec 17, 2009. The application was issued on Aug 3, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2374456

DAIICHI SANKYO
Application Number
EP09833467A
Filing Date
Dec 17, 2009
Status
Revoked
Apr 26, 2019
Publication Date
Aug 3, 2016